1. Home
  2. ASMB vs YSXT Comparison

ASMB vs YSXT Comparison

Compare ASMB & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • YSXT
  • Stock Information
  • Founded
  • ASMB 2005
  • YSXT 2011
  • Country
  • ASMB United States
  • YSXT China
  • Employees
  • ASMB N/A
  • YSXT N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • ASMB Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • ASMB 84.5M
  • YSXT 87.9M
  • IPO Year
  • ASMB 2010
  • YSXT 2024
  • Fundamental
  • Price
  • ASMB $13.42
  • YSXT $2.60
  • Analyst Decision
  • ASMB Buy
  • YSXT
  • Analyst Count
  • ASMB 2
  • YSXT 0
  • Target Price
  • ASMB $35.00
  • YSXT N/A
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • YSXT 74.7K
  • Earning Date
  • ASMB 03-27-2025
  • YSXT 01-01-0001
  • Dividend Yield
  • ASMB N/A
  • YSXT N/A
  • EPS Growth
  • ASMB N/A
  • YSXT N/A
  • EPS
  • ASMB N/A
  • YSXT 0.21
  • Revenue
  • ASMB $28,326,000.00
  • YSXT $58,546,729.00
  • Revenue This Year
  • ASMB $282.16
  • YSXT N/A
  • Revenue Next Year
  • ASMB N/A
  • YSXT N/A
  • P/E Ratio
  • ASMB N/A
  • YSXT $11.08
  • Revenue Growth
  • ASMB N/A
  • YSXT 18.92
  • 52 Week Low
  • ASMB $9.84
  • YSXT $2.06
  • 52 Week High
  • ASMB $19.93
  • YSXT $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.25
  • YSXT N/A
  • Support Level
  • ASMB $13.60
  • YSXT N/A
  • Resistance Level
  • ASMB $14.25
  • YSXT N/A
  • Average True Range (ATR)
  • ASMB 0.58
  • YSXT 0.00
  • MACD
  • ASMB -0.05
  • YSXT 0.00
  • Stochastic Oscillator
  • ASMB 5.93
  • YSXT 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: